AB2 Bio
AB2 Bio is a Lausanne-based medical diagnostics company involved in drug discovery and development for therapeutic solutions for inflammatory diseases founded in 2010 by Barthelemy Helg.
1
Funding Rounds
$20.8m
Money raised
Overview
AB2 Bio is a Lausanne-based medical diagnostics company involved in drug discovery and development for therapeutic solutions for inflammatory diseases founded in 2010 by Barthelemy Helg.
- Websites:
- Headquarters: Lausanne
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ba******** He** | - | - | - |
| Av***** Ka***** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| An**** Sl***** | - | - | - |
Funding series
Funding Series Analysis
The company AB2 Bio has raised a total of $20.79m in funding over 1 rounds.
Key Insights:
- AB2 Bio Series B round, January 2016: $20.79m
AB2 Bio Series B round, January 2016
$20.79m
Industries
AB2 Bio is active in the following industries: